Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
Launched by UNIVERSITY OF ALBERTA · Feb 19, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether individuals with Multiple Myeloma can safely participate in a customized exercise program while undergoing chemotherapy before a stem cell transplant. The main goal is to see if this exercise program—offered both in-person and online—can help improve or maintain physical fitness, muscle strength, and overall quality of life during treatment.
To join the study, participants need to be at least 18 years old, living in Alberta, and have a diagnosis of Multiple Myeloma that qualifies them for a stem cell transplant. They should be undergoing chemotherapy as part of their treatment. Participants will commit to a 10-week exercise program at the Cancer Rehabilitation Clinic at the University of Alberta, where they will receive support to help them stay active during this challenging time. If you or someone you know meets these criteria and is interested in improving health during treatment, this trial could be a valuable opportunity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Have a diagnosis of Multiple Myeloma
- • 2. Be transplant eligible
- • 3. Be undergoing chemotherapy prior to an autologous stem cell transplant as part of their cancer treatment
- • 4. Be an Alberta resident
- • 5. Be ≥18 years of age
- • 6. Be able to read and understand English.
- Exclusion Criteria:
- • 1. Their disease status/comorbidities preclude exercise testing or participation
- • 2. They are unable to commit to the 10-week exercise program and/or testing sessions at the Cancer Rehabilitation Clinic at the University of Alberta
- • 3. They do not have regular access to the internet and/or an electronic device in the home.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Chris Sellar, PhD
Study Director
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported